These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 22952347)
21. DLL4 expression is a prognostic marker and may predict gemcitabine benefit in resected pancreatic cancer. Drouillard A; Puleo F; Bachet JB; Ouazzani S; Calomme A; Demetter P; Verset G; Van Laethem JL; Maréchal R Br J Cancer; 2016 Nov; 115(10):1245-1252. PubMed ID: 27755532 [TBL] [Abstract][Full Text] [Related]
22. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer. Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310 [TBL] [Abstract][Full Text] [Related]
23. Loss of CCM3 impairs DLL4-Notch signalling: implication in endothelial angiogenesis and in inherited cerebral cavernous malformations. You C; Sandalcioglu IE; Dammann P; Felbor U; Sure U; Zhu Y J Cell Mol Med; 2013 Mar; 17(3):407-18. PubMed ID: 23388056 [TBL] [Abstract][Full Text] [Related]
24. ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models. Yeom DH; Lee YS; Ryu I; Lee S; Sung B; Lee HB; Kim D; Ahn JH; Ha E; Choi YS; Lee SH; You WK Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383646 [TBL] [Abstract][Full Text] [Related]
25. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Ubezio B; Blanco RA; Geudens I; Stanchi F; Mathivet T; Jones ML; Ragab A; Bentley K; Gerhardt H Elife; 2016 Apr; 5():. PubMed ID: 27074663 [TBL] [Abstract][Full Text] [Related]
26. Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Segarra M; Williams CK; Sierra Mde L; Bernardo M; McCormick PJ; Maric D; Regino C; Choyke P; Tosato G Blood; 2008 Sep; 112(5):1904-11. PubMed ID: 18577711 [TBL] [Abstract][Full Text] [Related]
27. A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel. Mato-Berciano A; Raimondi G; Maliandi MV; Alemany R; Montoliu L; Fillat C Oncotarget; 2017 Apr; 8(14):22700-22715. PubMed ID: 28186974 [TBL] [Abstract][Full Text] [Related]
28. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells. Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia. Al Haj Zen A; Oikawa A; Bazan-Peregrino M; Meloni M; Emanueli C; Madeddu P Circ Res; 2010 Jul; 107(2):283-93. PubMed ID: 20508179 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway. Fan J; Xu W; Nan S; Chang M; Zhang Y Cerebrovasc Dis; 2020; 49(1):39-54. PubMed ID: 31927543 [TBL] [Abstract][Full Text] [Related]
32. Regulation of multiple angiogenic pathways by Dll4 and Notch in human umbilical vein endothelial cells. Harrington LS; Sainson RC; Williams CK; Taylor JM; Shi W; Li JL; Harris AL Microvasc Res; 2008 Mar; 75(2):144-54. PubMed ID: 17692341 [TBL] [Abstract][Full Text] [Related]
33. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo. Hu GH; Liu H; Lai P; Guo ZF; Xu L; Yao XD; Zheng JH; Liu M; Xu YF Int J Clin Exp Pathol; 2014; 7(5):2143-52. PubMed ID: 24966922 [TBL] [Abstract][Full Text] [Related]
34. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Wang Z; Li Y; Kong D; Banerjee S; Ahmad A; Azmi AS; Ali S; Abbruzzese JL; Gallick GE; Sarkar FH Cancer Res; 2009 Mar; 69(6):2400-7. PubMed ID: 19276344 [TBL] [Abstract][Full Text] [Related]
35. Arsenic Trioxide Suppresses Tumor Growth through Antiangiogenesis via Notch Signaling Blockade in Small-Cell Lung Cancer. Yang MH; Chang KJ; Li B; Chen WS Biomed Res Int; 2019; 2019():4647252. PubMed ID: 31093499 [TBL] [Abstract][Full Text] [Related]
36. Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth. Oon CE; Bridges E; Sheldon H; Sainson RCA; Jubb A; Turley H; Leek R; Buffa F; Harris AL; Li JL Oncotarget; 2017 Jun; 8(25):40115-40131. PubMed ID: 28445154 [TBL] [Abstract][Full Text] [Related]
37. Angiopoietin-1/Tie2 signal augments basal Notch signal controlling vascular quiescence by inducing delta-like 4 expression through AKT-mediated activation of beta-catenin. Zhang J; Fukuhara S; Sako K; Takenouchi T; Kitani H; Kume T; Koh GY; Mochizuki N J Biol Chem; 2011 Mar; 286(10):8055-8066. PubMed ID: 21212269 [TBL] [Abstract][Full Text] [Related]
38. High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer. Negri F; Bozzetti C; Pedrazzi G; Azzoni C; Bottarelli L; Squadrilli A; Lagrasta C; Tamagnini I; Bisagni A; Ragazzi M; Porzio R; Tomasello G; Mori D; Leonardi F; Gnetti L; Crafa P; Sala R; Cascinu S Oncol Rep; 2019 Dec; 42(6):2750-2758. PubMed ID: 31578584 [TBL] [Abstract][Full Text] [Related]